 |
市场调查报告书
商品编码
1908017
碎片分析市场：按技术、产品/服务、碎片类型、应用、最终用户和地区划分Fragment Analysis Market, By Technology, By Product and Service, By Fragment Type, By Application, By End User, By Geography |
||||||
2025 年碎片分析市场规模预计为 2.813 亿美元，预计到 2032 年将达到 5.412 亿美元，2025 年至 2032 年的复合年增长率为 9.8%。
| 报告内容 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2024 | 2025年市场规模： | 2.813亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2025年至2032年 |
| 预测期（2025-2032年）复合年增长率： | 9.80% | 2032 年的预测值： | 5.412亿美元 |
片段分析是一种先进的分子生物学技术，它能够根据DNA和RNA片段的大小和分子特性，对其进行精确的分离、鑑定和定量。这种分析方法在基因组学、蛋白质组学、法医学、临床诊断和药物研发等多个科学领域都至关重要。全球片段分析市场涵盖了各种仪器、试剂、耗材和软体解决方案，能够以极高的准确性和效率实现高解析度的基因分析。
片段分析技术利用毛细管电泳、自动化定序平台和先进的检测系统，为研究人员和临床医生提供详细的分子讯息，这些资讯对于微卫星分析、杂合性缺失研究、比较基因组杂合反应和单核苷酸多态性检测等应用至关重要。受个人化医疗需求不断增长、癌症研究应用日益广泛、遗传疾病患病率上升以及分析仪器技术的持续进步等因素的推动，该市场正经历显着增长。随着全球医疗保健系统将精准医疗和标靶治疗方法列为优先事项，片段分析已成为理解基因变异、识别疾病生物标记和开发新型治疗性介入的关键平台技术，预计将在各种研发和临床环境中持续扩展。
市场动态
全球片段分析市场受多种强劲驱动因素的推动，这些因素持续塑造其成长轨迹，并拓展其在多个领域的应用范围。其中一个关键驱动因素源于基因组研究和个人化医疗倡议的指数级增长，片段分析在识别基因变异、突变和多态性方面发挥关键作用，而这些对于制定标靶治疗策略和诊断通讯协定至关重要。全球遗传疾病和癌症的日益普及显着推动了对精准分子诊断工具的需求，而片段分析能够为研究人员和临床医生提供复杂基因研究和临床决策所需的精确度和解析度。
毛细管电泳系统、自动化平台和高通量定序技术的进步提高了片段分析程序的效率、速度和成本效益，使这些解决方案更容易被研究机构、临床检查室和製药公司所采用。
然而，该市场也面临诸多限制，包括先进碎片分析设备所需的大量初始投资、需要专门技术知识的复杂操作要求，以及可能延迟新产品核可和市场准入的严格监管合规标准。
此外，替代分析方法的激增和新兴定序技术的竞争也为市场扩张带来了挑战。儘管有这些限制，但仍存在巨大的机会，包括新兴国家对片段分析的日益普及、农业基因组学和环境监测领域应用范围的扩大、政府对基因组研究项目的资助增加，以及携带式、易于使用的仪器的开发，使得先进的分子分析能力能够在各种实验室环境和地区广泛应用。
本次调查的主要特点
- 本报告以 2024 年为基准年，对全球碎片分析市场进行了详细分析，并给出了预测期（2025-2032 年）内的市场规模和复合年增长率（%）。
- 它还重点介绍了不同细分市场的潜在商机，并概述了该市场具有吸引力的投资提案矩阵。
- 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 该报告根据以下参数对全球碎片分析市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务绩效和策略。
- 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 这份全球碎片分析市场报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 相关人员可以透过用于分析全球碎片分析市场的各种策略矩阵轻鬆做出决策。
目录
第一章 研究目标与前提条件
- 调查目的
- 先决条件
- 简称
第二章 市场范围
- 报告概述
- 市场定义和范围
- 执行摘要
第三章 市场动态、监理及趋势分析
- 市场动态
- 司机
- 抑制因素
- 机会
- 影响分析
- 重大进展
- 法规环境
- 产品上市及核准
- PEST分析
- 波特分析
- 併购趋势
- 产业趋势
4. 2020-2032年全球碎片分析市场（依技术划分）
- 基于聚合酵素链锁反应（PCR）的片段分析
- 毛细管电泳（CE）
- 基于次世代定序（NGS）的片段分析
- 微流体和实验室晶片碎片分析
- 凝胶电泳（琼脂糖/聚丙烯酰胺）
5. 2020-2032年全球产品与服务細項分析市场
- 装置
- 耗材和试剂
- 软体和服务
6. 2020-2032年全球碎片分析市场（以碎片类型划分）
- DNA片段
- RNA片段
- 蛋白质片段（小批量、小众应用）
7. 2020-2032年全球碎片分析市场（依应用领域划分）
- 核酸分析
- 品管和认证
- DNA指纹图谱与法医学
8. 2020-2032年全球碎片分析市场（依最终用户划分）
- 临床诊断检查室
- 医院
- 研究和学术机构
- 生物製药和生物技术公司
- 受託研究机构（CRO）
9. 2020-2032年全球碎片分析市场（按地区划分）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
- 非洲
- 南非
- 北非
- 中非
第十章 竞争格局
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN NV
- Promega Corporation
- PerkinElmer Inc.（Revvity）
- Merck KGaA（MilliporeSigma）
- Hoffmann-La Roche Ltd.
- Illumina Inc.
- Abbott Laboratories
- New England Biolabs Inc.
- Takara Bio Inc.
- SCIEX
- LGC Group
第十一章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十二章 参考文献与调查方法
- 参考
- 调查方法
- 关于本公司
Fragment Analysis Market is estimated to be valued at USD 281.3 Mn in 2025 and is expected to reach USD 541.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 281.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.80% | 2032 Value Projection: | USD 541.2 Mn |
Fragment analysis represents a sophisticated molecular biology technique that enables precise separation, identification, and quantification of DNA and RNA fragments based on their size and molecular characteristics. This analytical method has become indispensable in various scientific disciplines, including genomics, proteomics, forensics, clinical diagnostics, and pharmaceutical research. The global fragment analysis market encompasses a comprehensive range of instruments, reagents, consumables, and software solutions designed to facilitate high-resolution genetic analysis with exceptional accuracy and efficiency.
Fragment analysis technologies utilize capillary electrophoresis, automated sequencing platforms, and advanced detection systems to provide researchers and clinicians with detailed molecular insights essential for applications such as microsatellite analysis, loss of heterozygosity studies, comparative genomic hybridization, and single nucleotide polymorphism detection. The market has witnessed substantial growth driven by increasing demand for personalized medicine, expanding applications in cancer research, rising prevalence of genetic disorders, and continuous technological advancements in analytical instrumentation. As healthcare systems worldwide prioritize precision medicine and targeted therapeutic approaches, fragment analysis has emerged as a critical enabler for understanding genetic variations, identifying disease biomarkers, and developing novel therapeutic interventions, positioning this market for sustained expansion across diverse research and clinical environments.
Market Dynamics
The global fragment analysis market is propelled by several compelling drivers that continue to shape its growth trajectory and expand its applications across multiple sectors. The primary driver stems from the exponential growth in genomics research and personalized medicine initiatives, where fragment analysis plays a crucial role in identifying genetic variations, mutations, and polymorphisms essential for developing targeted therapeutic strategies and diagnostic protocols. The increasing prevalence of genetic disorders and cancer worldwide has significantly amplified the demand for precise molecular diagnostic tools, with fragment analysis providing researchers and clinicians with the accuracy and resolution required for complex genetic studies and clinical decision-making.
Technological advancements in capillary electrophoresis systems, automated platforms, and high-throughput sequencing technologies have enhanced the efficiency, speed, and cost-effectiveness of fragment analysis procedures, making these solutions more accessible to research institutions, clinical laboratories, and pharmaceutical companies.
However, the market faces notable restraints including high initial capital investments required for advanced fragment analysis instruments, complex operational requirements demanding specialized technical expertise, and stringent regulatory compliance standards that can delay product approvals and market entry for new technologies.
Additionally, the availability of alternative analytical methods and competition from emerging sequencing technologies pose challenges to market expansion. Despite these constraints, significant opportunities exist in the growing adoption of fragment analysis in emerging economies, expanding applications in agricultural genomics and environmental monitoring, increasing government funding for genomics research programs, and the development of portable, user-friendly instruments that can democratize access to sophisticated molecular analysis capabilities across diverse laboratory settings and geographical regions.
Key Features of the Study
- This report provides in-depth analysis of the global fragment analysis market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fragment analysis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, PerkinElmer Inc. (Revvity), Merck KGaA (MilliporeSigma), F. Hoffmann-La Roche Ltd., Illumina Inc., Abbott Laboratories, New England Biolabs Inc., Takara Bio Inc., SCIEX, and LGC Group
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fragment analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fragment analysis market
Market Segmentation
- Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Capillary Electrophoresis (CE)
- Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Microfluidics and Lab-on-Chip Fragment Analysis
- Gel Electrophoresis (Agarose/Polyacrylamide)
- Product and Service Insights (Revenue, USD Mn, 2020 - 2032)
- Instruments
- Genetic Analyzers/Sequencers
- PCR Systems
- Microarray Scanners
- Other Instruments
- Consumables and Reagents
- Kits and Assays
- Enzymes and Master Mixes
- Standards and Size Markers
- Other Reagents
- Software and Services
- Fragment Type Insights (Revenue, USD Mn, 2020 - 2032)
- DNA Fragments
- RNA Fragments
- Protein Fragments (Low-use, niche applications)
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Nucleic Acid Analysis
- Genotyping (SSR, SNP)
- Mutation Detection and Sequencing
- Others (Microsatellite Instability Analysis, etc.)
- Quality Control and Validation
- Next-Generation Sequencing Library QC
- CRISPR Edit Confirmation
- Others (PCR Product Verification, etc.)
- Genetic Fingerprinting and Forensics
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Clinical Diagnostics Laboratories
- Hospitals
- Research and Academic Institutes
- Biopharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Promega Corporation
- PerkinElmer Inc. (Revvity)
- Merck KGaA (MilliporeSigma)
- Hoffmann-La Roche Ltd.
- Illumina Inc.
- Abbott Laboratories
- New England Biolabs Inc.
- Takara Bio Inc.
- SCIEX
- LGC Group
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Fragment Analysis Market, By Technology
- Global Fragment Analysis Market, By Product and Service
- Global Fragment Analysis Market, By Fragment Type
- Global Fragment Analysis Market, By Application
- Global Fragment Analysis Market, By End User
- Global Fragment Analysis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Fragment Analysis Market, By Technology, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Polymerase Chain Reaction (PCR)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Capillary Electrophoresis (CE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Next-Generation Sequencing (NGS)-Based Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Microfluidics and Lab-on-Chip Fragment Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Gel Electrophoresis (Agarose/Polyacrylamide)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Fragment Analysis Market, By Product and Service, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Genetic Analyzers/Sequencers
- PCR Systems
- Microarray Scanners
- Other Instruments
- Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Kits and Assays
- Enzymes and Master Mixes
- Standards and Size Markers
- Other Reagents
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Fragment Analysis Market, By Fragment Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- DNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- RNA Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Protein Fragments (Low-use, niche applications)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Fragment Analysis Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Nucleic Acid Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Genotyping (SSR, SNP)
- Mutation Detection and Sequencing
- Others (Microsatellite Instability Analysis, etc.)
- Quality Control and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Next-Generation Sequencing Library QC
- CRISPR Edit Confirmation
- Others (PCR Product Verification, etc.)
- Genetic Fingerprinting and Forensics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Fragment Analysis Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Clinical Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Biopharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Fragment Analysis Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Fragment Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc. (Revvity)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SCIEX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LGC Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
药物发现市场规模、份额和成长分析（按流程、药物类型、技术、治疗领域、服务供应商和地区划分）－2026-2033年产业预测
抗体优化服务市场规模、份额和趋势分析报告：按类型、技术、应用、最终用途、地区和细分市场预测（2025-2033 年）
本地活动发现平台市场预测至2032年：按平台类型、活动类型、收入模式、功能整合、部署类型、最终用户和地区分類的全球分析
动物用药品市场人工智慧分析及2034年预测：类型、产品、服务、技术、应用、组件、最终用户、部署、阶段和解决方案
囊泡转运蛋白检测市场按技术平台、产品形式、最终用户、应用和转运蛋白类别划分－2025-2032年全球预测按药物类型、技术和治疗领域分類的药物研发市场—2025-2032 年全球预测2032 年减重药物研究市场预测：按平台、药物、技术、应用、最终用户和地区进行的全球分析预测药物反应模型的人工智慧市场分析及预测（至 2034 年）：类型、产品、服务、技术、组件、应用、最终用户、功能、部署和解决方案
药物发现平台市场：产业趋势及全球预测 - 依显示库技术类型、分子类型和主要地区
药物研发平台市场：按药物类型、技术、治疗领域、应用、最终用户和地区划分